vs
Side-by-side financial comparison of James River Group Holdings, Inc. (JRVR) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $151.4M, roughly 1.4× James River Group Holdings, Inc.). On growth, Varex Imaging Corp posted the faster year-over-year revenue change (4.9% vs -12.1%). Over the past eight quarters, Varex Imaging Corp's revenue compounded faster (0.8% CAGR vs -10.3%).
James River Corporation was an American pulp and paper company based in Richmond, Virginia, once the largest paper manufacturer in the world.
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
JRVR vs VREX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $151.4M | $209.6M |
| Net Profit | — | $2.3M |
| Gross Margin | — | 33.3% |
| Operating Margin | — | 7.3% |
| Net Margin | — | 1.1% |
| Revenue YoY | -12.1% | 4.9% |
| Net Profit YoY | — | 866.7% |
| EPS (diluted) | — | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $151.4M | $209.6M | ||
| Q4 25 | $167.7M | $228.9M | ||
| Q3 25 | $172.7M | $203.0M | ||
| Q2 25 | $174.8M | $212.9M | ||
| Q1 25 | $172.3M | $199.8M | ||
| Q4 24 | $126.7M | — | ||
| Q3 24 | $191.5M | $205.7M | ||
| Q2 24 | $188.3M | $209.1M |
| Q1 26 | — | $2.3M | ||
| Q4 25 | $32.1M | $12.2M | ||
| Q3 25 | $1.0M | $-89.1M | ||
| Q2 25 | $4.8M | $6.9M | ||
| Q1 25 | $9.6M | $-300.0K | ||
| Q4 24 | $-64.8M | — | ||
| Q3 24 | $-39.4M | $-51.1M | ||
| Q2 24 | $7.6M | $1.4M |
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 14.6% | 8.6% | ||
| Q3 25 | 1.5% | -39.8% | ||
| Q2 25 | 4.2% | 10.4% | ||
| Q1 25 | 9.3% | 5.6% | ||
| Q4 24 | -57.0% | — | ||
| Q3 24 | -27.1% | 5.3% | ||
| Q2 24 | 10.7% | 4.4% |
| Q1 26 | — | 1.1% | ||
| Q4 25 | 19.1% | 5.3% | ||
| Q3 25 | 0.6% | -43.9% | ||
| Q2 25 | 2.7% | 3.2% | ||
| Q1 25 | 5.6% | -0.2% | ||
| Q4 24 | -51.1% | — | ||
| Q3 24 | -20.6% | -24.8% | ||
| Q2 24 | 4.0% | 0.7% |
| Q1 26 | — | $0.05 | ||
| Q4 25 | $0.59 | $0.29 | ||
| Q3 25 | $-0.02 | $-2.15 | ||
| Q2 25 | $0.06 | $0.17 | ||
| Q1 25 | $0.16 | $-0.01 | ||
| Q4 24 | $-2.44 | — | ||
| Q3 24 | $-1.10 | $-1.25 | ||
| Q2 24 | $0.13 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.2M | $125.6M |
| Total DebtLower is stronger | — | $367.6M |
| Stockholders' EquityBook value | $518.4M | $476.9M |
| Total Assets | $4.8B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $228.2M | $125.6M | ||
| Q4 25 | $260.9M | $155.1M | ||
| Q3 25 | $238.8M | $152.6M | ||
| Q2 25 | $220.0M | $223.0M | ||
| Q1 25 | $279.4M | $212.6M | ||
| Q4 24 | $362.3M | — | ||
| Q3 24 | $359.8M | $200.5M | ||
| Q2 24 | $672.5M | $190.0M |
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | $518.4M | $476.9M | ||
| Q4 25 | $538.2M | $472.6M | ||
| Q3 25 | $503.6M | $455.3M | ||
| Q2 25 | $492.6M | $549.7M | ||
| Q1 25 | $484.5M | $540.2M | ||
| Q4 24 | $460.9M | — | ||
| Q3 24 | $530.3M | $529.1M | ||
| Q2 24 | $541.8M | $581.2M |
| Q1 26 | $4.8B | $1.1B | ||
| Q4 25 | $4.9B | $1.1B | ||
| Q3 25 | $5.0B | $1.1B | ||
| Q2 25 | $5.0B | $1.4B | ||
| Q1 25 | $4.9B | $1.3B | ||
| Q4 24 | $5.0B | — | ||
| Q3 24 | $5.0B | $1.2B | ||
| Q2 24 | $4.7B | $1.3B |
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-16.1M |
| Free Cash FlowOCF − Capex | — | $-26.8M |
| FCF MarginFCF / Revenue | — | -12.8% |
| Capex IntensityCapex / Revenue | — | 5.1% |
| Cash ConversionOCF / Net Profit | — | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $-18.8M | $7.9M | ||
| Q3 25 | $34.3M | $7.7M | ||
| Q2 25 | $25.2M | $16.6M | ||
| Q1 25 | $-51.5M | $9.5M | ||
| Q4 24 | $-247.1M | — | ||
| Q3 24 | $-269.9M | $25.9M | ||
| Q2 24 | $-8.7M | $8.0M |
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $-23.6M | $2.3M | ||
| Q3 25 | $33.7M | $1.4M | ||
| Q2 25 | $24.7M | $9.8M | ||
| Q1 25 | $-52.7M | $5.3M | ||
| Q4 24 | $-252.0M | — | ||
| Q3 24 | $-270.8M | $19.9M | ||
| Q2 24 | $-9.3M | $3.3M |
| Q1 26 | — | -12.8% | ||
| Q4 25 | -14.1% | 1.0% | ||
| Q3 25 | 19.5% | 0.7% | ||
| Q2 25 | 14.1% | 4.6% | ||
| Q1 25 | -30.6% | 2.7% | ||
| Q4 24 | -198.9% | — | ||
| Q3 24 | -141.4% | 9.7% | ||
| Q2 24 | -4.9% | 1.6% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | 2.9% | 2.4% | ||
| Q3 25 | 0.4% | 3.1% | ||
| Q2 25 | 0.3% | 3.2% | ||
| Q1 25 | 0.7% | 2.1% | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 0.4% | 2.9% | ||
| Q2 24 | 0.3% | 2.2% |
| Q1 26 | — | -7.00× | ||
| Q4 25 | -0.59× | 0.65× | ||
| Q3 25 | 33.61× | — | ||
| Q2 25 | 5.29× | 2.41× | ||
| Q1 25 | -5.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.14× | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JRVR
Segment breakdown not available.
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
